Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 53% ± 13% | |
endothelial cell | 11 studies | 25% ± 6% | |
epithelial cell | 10 studies | 36% ± 12% | |
basal cell | 6 studies | 35% ± 21% | |
goblet cell | 6 studies | 28% ± 8% | |
endothelial cell of vascular tree | 6 studies | 24% ± 6% | |
respiratory goblet cell | 5 studies | 34% ± 5% | |
secretory cell | 5 studies | 28% ± 8% | |
endothelial cell of artery | 5 studies | 19% ± 1% | |
deuterosomal cell | 4 studies | 45% ± 6% | |
vein endothelial cell | 4 studies | 23% ± 5% | |
abnormal cell | 4 studies | 28% ± 3% | |
brush cell | 4 studies | 29% ± 16% | |
kidney loop of Henle epithelial cell | 3 studies | 24% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 34% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 95% | 10483.31 | 340 / 359 | 95% | 200.77 | 271 / 286 |
bladder | 100% | 3758.29 | 21 / 21 | 88% | 216.78 | 445 / 504 |
esophagus | 95% | 3682.81 | 1379 / 1445 | 91% | 219.01 | 167 / 183 |
breast | 98% | 3787.63 | 451 / 459 | 88% | 176.80 | 986 / 1118 |
intestine | 86% | 2371.89 | 830 / 966 | 93% | 218.84 | 488 / 527 |
thymus | 99% | 6416.19 | 647 / 653 | 72% | 110.13 | 433 / 605 |
lung | 87% | 1881.08 | 502 / 578 | 83% | 267.27 | 961 / 1155 |
kidney | 99% | 4218.33 | 88 / 89 | 44% | 61.63 | 398 / 901 |
adrenal gland | 100% | 4637.20 | 257 / 258 | 27% | 34.06 | 62 / 230 |
uterus | 50% | 549.03 | 85 / 170 | 75% | 140.04 | 346 / 459 |
skin | 47% | 5453.18 | 848 / 1809 | 68% | 104.15 | 321 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 148.41 | 1 / 1 |
brain | 81% | 1757.18 | 2138 / 2642 | 19% | 11.23 | 131 / 705 |
adipose | 99% | 4955.00 | 1192 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 7% | 60.93 | 24 / 328 | 91% | 223.95 | 162 / 178 |
prostate | 65% | 893.51 | 160 / 245 | 32% | 20.82 | 163 / 502 |
blood vessel | 94% | 1952.38 | 1257 / 1335 | 0% | 0 | 0 / 0 |
ovary | 17% | 220.50 | 30 / 180 | 58% | 48.23 | 250 / 430 |
spleen | 73% | 1040.22 | 175 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 56% | 95.78 | 25 / 45 |
eye | 0% | 0 | 0 / 0 | 53% | 57.20 | 42 / 80 |
muscle | 48% | 781.41 | 386 / 803 | 0% | 0 | 0 / 0 |
liver | 5% | 52.83 | 11 / 226 | 42% | 154.74 | 172 / 406 |
heart | 44% | 552.77 | 376 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 17% | 275.76 | 158 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 3.16 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007584 | Biological process | response to nutrient |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0032355 | Biological process | response to estradiol |
GO_0033574 | Biological process | response to testosterone |
GO_0014075 | Biological process | response to amine |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0002931 | Biological process | response to ischemia |
GO_0000209 | Biological process | protein polyubiquitination |
GO_1904844 | Biological process | response to L-glutamine |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0045087 | Biological process | innate immune response |
GO_1905395 | Biological process | response to flavonoid |
GO_0110076 | Biological process | negative regulation of ferroptosis |
GO_0043279 | Biological process | response to alkaloid |
GO_1904880 | Biological process | response to hydrogen sulfide |
GO_0042360 | Biological process | vitamin E metabolic process |
GO_0045471 | Biological process | response to ethanol |
GO_1904772 | Biological process | response to tetrachloromethane |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0006116 | Biological process | NADH oxidation |
GO_0042373 | Biological process | vitamin K metabolic process |
GO_0009725 | Biological process | response to hormone |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006809 | Biological process | nitric oxide biosynthetic process |
GO_0009743 | Biological process | response to carbohydrate |
GO_0071248 | Biological process | cellular response to metal ion |
GO_0030163 | Biological process | protein catabolic process |
GO_0070995 | Biological process | NADPH oxidation |
GO_0009636 | Biological process | response to toxic substance |
GO_0019430 | Biological process | removal of superoxide radicals |
GO_0006743 | Biological process | ubiquinone metabolic process |
GO_0006979 | Biological process | response to oxidative stress |
GO_0007271 | Biological process | synaptic transmission, cholinergic |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008753 | Molecular function | NADPH dehydrogenase (quinone) activity |
GO_0050136 | Molecular function | NADH:ubiquinone reductase (non-electrogenic) activity |
GO_0004128 | Molecular function | cytochrome-b5 reductase activity, acting on NAD(P)H |
GO_0003955 | Molecular function | NAD(P)H dehydrogenase (quinone) activity |
GO_0004784 | Molecular function | superoxide dismutase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NQO1 |
Protein name | NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1) Alternative protein NQO1 |
Synonyms | hCG_28204 NMOR1 DIA4 |
Description | FUNCTION: Flavin-containing quinone reductase that catalyzes two-electron reduction of quinones to hydroquinones using either NADH or NADPH as electron donors. In a ping-pong kinetic mechanism, the electrons are sequentially transferred from NAD(P)H to flavin cofactor and then from reduced flavin to the quinone, bypassing the formation of semiquinone and reactive oxygen species (By similarity). Regulates cellular redox state primarily through quinone detoxification. Reduces components of plasma membrane redox system such as coenzyme Q and vitamin quinones, producing antioxidant hydroquinone forms. In the process may function as superoxide scavenger to prevent hydroquinone oxidation and facilitate excretion . Alternatively, can activate quinones and their derivatives by generating redox reactive hydroquinones with DNA cross-linking antitumor potential . Acts as a gatekeeper of the core 20S proteasome known to degrade proteins with unstructured regions. Upon oxidative stress, interacts with tumor suppressors TP53 and TP73 in a NADH-dependent way and inhibits their ubiquitin-independent degradation by the 20S proteasome . . |
Accessions | ENST00000379046.6 [P15559-3] H3BRK3 P15559 Q3B792 L8E9G5 ENST00000439109.6 H3BNV2 L8EC59 ENST00000379047.7 [P15559-2] ENST00000564043.1 ENST00000561500.5 B4DLR8 ENST00000320623.10 [P15559-1] |